Innovating Works

NPSS

Desconocido
EE-ASI: Beta cell preservation via antigen specific immunotherapy in Type 1 Diabetes Enhanced Epidermal Ant... NANOPASS TECHNOLOGIES LTD participó en un FP7: Current approaches to improving glycaemic control in type 1 diabetes are centered on increasingly complex insulin delivery systems. However...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.